Drugs / PF-07940369
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07514156 | Jul 2025 → Jan 2026 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT06532383 | Aug 2024 → Jan 2025 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07940369 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07514156 ↗ |
| Route | Oral | “All treatments will be taken by mouth.” NCT06532383 ↗ |